However, the causal associations of genetically proxied CETP inhibition with RCC risk in women attenuated substantially after adjusting for BMI (P = 0.409), height (P = 0.647), systolic pressure (P = 0.985), and diastolic pressure (P = 0.765). The gene discussed is CETP; the disease is renal cell carcinoma.